GLP-1 receptor agonists
AssessTechniques
A class of drugs that mimic GLP-1 to regulate appetite and metabolism.
Why it's here
Placed in Assess: 4 article(s) of evidence from 1 source(s), led by research-stage coverage, with 1 in the last 30 days. Confidence 42%.
Evidence (4)
- 5Hacker News·9/3/2026researchGLP-1 drugs linked to fewer serious infections, including TB
A reported study links GLP-1 drugs to a lower risk of serious infections, including tuberculosis. The finding suggests these medications may have effects beyond weight loss and blood sugar control, but it remains an observational result that would need further confirmation.
- 6Hacker News·8/11/2026researchBrain weight-loss drugs may be nearing a breakthrough
The article argues that neuroscience could be approaching a GLP-1-like turning point, with new drugs or interventions potentially offering major benefits for brain-related conditions. It frames this as an emerging research area rather than a finished treatment, with evidence still developing and clinical impact yet to be proven.
- 6Hacker News·8/10/2026researchHarvard study finds GLP-1 drugs may boost women’s employment
A Harvard/NBER working paper reports that women who started GLP-1 weight-loss drugs while unemployed were about 27 percentage points more likely to be employed 18 months later than similar women who had not started treatment. The study suggests appearance-related bias may influence hiring and broader labor-market outcomes, rather than indicating any change in capability from the drugs themselves.
- 5Hacker News·6/27/2026researchOzempic May Affect Mood Through the Gut-Brain Axis
A reported study suggests GLP-1 drugs such as Ozempic and liraglutide may do more than support weight loss by also reducing depression-like behavior in mice. The effect appears to depend on gut microbes, especially Lactobacillus delbrueckii, which may produce endocannabinoids linked to stress reduction.